Rilonacept and Anakinra in Recurrent Pericarditis: A Systematic Review and Meta-Analysis

Interleukin 1 (IL-1) has been indicated as a mediator of recurrent pericarditis. Rilonacept, a soluble IL-1 receptor chimeric fusion protein neutralizing interleukin 1 alpha (IL-1α) and interleukin 1 beta (IL-1β), has demonstrated promising results in a phase II study in recurrent or refractory peri...

Descripción completa

Detalles Bibliográficos
Autores principales: Affas, Ziad R, Rasool, Banan Q, Sebastian, Sneha A, Affas, Rafe S, Mohamadtahr, Sayran K, Saoor, Nagham H, Mohammad, Aya N, Saoor, Ghada H, Husain, Bzhar A, Touza, Rowaid, Touza, Ghaid, Amen, Shwan, Nazzaro, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730293/
https://www.ncbi.nlm.nih.gov/pubmed/36505131
http://dx.doi.org/10.7759/cureus.31226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730293/
https://www.ncbi.nlm.nih.gov/pubmed/36505131
http://dx.doi.org/10.7759/cureus.31226

Ejemplares similares